Publication Information

{'id': 'https://openalex.org/W2981596434', 'doi': None, 'title': 'Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide.', 'display_name': 'Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide.', 'publication_year': 2017, 'publication_date': '2017-09-01', 'ids': {'openalex': 'https://openalex.org/W2981596434', 'mag': '2981596434', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/28975013', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/5620511'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://europepmc.org/articles/PMC5620511', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765035179', 'display_name': 'American health & drug benefits', 'issn_l': '1942-2962', 'issn': ['1942-2962'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5113805125', 'display_name': 'Ajay S. Behl', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4391767992', 'display_name': 'Janssen Scientific Affairs (United States)', 'ror': 'https://ror.org/04w4xsz15', 'country_code': None, 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4391767992']}, {'id': 'https://openalex.org/I4210151386', 'display_name': 'Janssen (United States)', 'ror': 'https://ror.org/05af73403', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4210151386']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ajay S Behl', 'raw_affiliation_strings': ['Director of US Oncology Economics and Outcomes Research, Janssen Scientific Affairs, Titusville, NJ.'], 'affiliations': [{'raw_affiliation_string': 'Director of US Oncology Economics and Outcomes Research, Janssen Scientific Affairs, Titusville, NJ.', 'institution_ids': ['https://openalex.org/I4391767992', 'https://openalex.org/I4210151386']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033380416', 'display_name': 'Lorie Ellis', 'orcid': 'https://orcid.org/0000-0002-9798-6982'}, 'institutions': [{'id': 'https://openalex.org/I4391767992', 'display_name': 'Janssen Scientific Affairs (United States)', 'ror': 'https://ror.org/04w4xsz15', 'country_code': None, 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4391767992']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Lorie A Ellis', 'raw_affiliation_strings': ['Director of US Rheumatology Economics and Outcomes Research, Janssen Scientific Affairs.'], 'affiliations': [{'raw_affiliation_string': 'Director of US Rheumatology Economics and Outcomes Research, Janssen Scientific Affairs.', 'institution_ids': ['https://openalex.org/I4391767992', 'https://openalex.org/I137982388']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090831117', 'display_name': 'Dominic Pilon', 'orcid': 'https://orcid.org/0000-0002-6093-7167'}, 'institutions': [{'id': 'https://openalex.org/I4210133247', 'display_name': 'Group for Research in Decision Analysis', 'ror': 'https://ror.org/02pkvpx84', 'country_code': 'CA', 'type': 'facility', 'lineage': ['https://openalex.org/I108192572', 'https://openalex.org/I159129438', 'https://openalex.org/I4210133247', 'https://openalex.org/I45683168', 'https://openalex.org/I49663120', 'https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Dominic Pilon', 'raw_affiliation_strings': ["Manager, Groupe d'analyse, Montréal, Québec, Canada."], 'affiliations': [{'raw_affiliation_string': "Manager, Groupe d'analyse, Montréal, Québec, Canada.", 'institution_ids': ['https://openalex.org/I4210133247']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016377572', 'display_name': 'Yongling Xiao', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Yongling Xiao', 'raw_affiliation_strings': ["Associate, Groupe d'analyse."], 'affiliations': [{'raw_affiliation_string': "Associate, Groupe d'analyse.", 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5105457474', 'display_name': 'Patrick Lefèbvre', 'orcid': 'https://orcid.org/0000-0002-2216-5442'}, 'institutions': [{'id': 'https://openalex.org/I140141095', 'display_name': 'ING Direct', 'ror': 'https://ror.org/05dwsnj39', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I140141095']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Patrick Lefebvre', 'raw_affiliation_strings': ["Managing Principal, Groupe d'analyse."], 'affiliations': [{'raw_affiliation_string': "Managing Principal, Groupe d'analyse.", 'institution_ids': ['https://openalex.org/I140141095']}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 5, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.573, 'has_fulltext': False, 'cited_by_count': 30, 'citation_normalized_percentile': {'value': 0.904066, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '10', 'issue': '6', 'first_page': '296', 'last_page': '303'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9976, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9976, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.9760728}, {'id': 'https://openalex.org/keywords/abiraterone-acetate', 'display_name': 'Abiraterone acetate', 'score': 0.9381937}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.9760728}, {'id': 'https://openalex.org/C2775832370', 'wikidata': 'https://www.wikidata.org/wiki/Q27888393', 'display_name': 'Abiraterone acetate', 'level': 5, 'score': 0.9381937}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.83015096}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.77762306}, {'id': 'https://openalex.org/C207103383', 'wikidata': 'https://www.wikidata.org/wiki/Q3930246', 'display_name': 'Hazard ratio', 'level': 3, 'score': 0.6703961}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.51613176}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5068076}, {'id': 'https://openalex.org/C50382708', 'wikidata': 'https://www.wikidata.org/wiki/Q223218', 'display_name': 'Proportional hazards model', 'level': 2, 'score': 0.46748155}, {'id': 'https://openalex.org/C2781190966', 'wikidata': 'https://www.wikidata.org/wiki/Q420436', 'display_name': 'Docetaxel', 'level': 3, 'score': 0.41894948}, {'id': 'https://openalex.org/C126894567', 'wikidata': 'https://www.wikidata.org/wiki/Q105650', 'display_name': 'Urology', 'level': 1, 'score': 0.37134323}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.37036306}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.31755874}, {'id': 'https://openalex.org/C2777899217', 'wikidata': 'https://www.wikidata.org/wiki/Q4759439', 'display_name': 'Androgen deprivation therapy', 'level': 4, 'score': 0.30639043}, {'id': 'https://openalex.org/C44249647', 'wikidata': 'https://www.wikidata.org/wiki/Q208498', 'display_name': 'Confidence interval', 'level': 2, 'score': 0.15527526}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.10233018}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://europepmc.org/articles/PMC5620511', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765035179', 'display_name': 'American health & drug benefits', 'issn_l': '1942-2962', 'issn': ['1942-2962'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.79, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3204692896', 'https://openalex.org/W3163701401', 'https://openalex.org/W3016741390', 'https://openalex.org/W3008213884', 'https://openalex.org/W3001258159', 'https://openalex.org/W2978712413', 'https://openalex.org/W2890867692', 'https://openalex.org/W2810806599', 'https://openalex.org/W2801282149', 'https://openalex.org/W2792750979', 'https://openalex.org/W2782525017', 'https://openalex.org/W2618964027', 'https://openalex.org/W2614607222', 'https://openalex.org/W2603573817', 'https://openalex.org/W2590570123', 'https://openalex.org/W2589166085', 'https://openalex.org/W2166918329', 'https://openalex.org/W2148643283', 'https://openalex.org/W2137467802', 'https://openalex.org/W2055346449'], 'abstract_inverted_index': {'BACKGROUND': [0], 'The': [1, 95, 177], 'efficacy': [2], 'of': [3, 227, 295, 314, 321], 'and': [4, 30, 42, 89, 104, 126, 135, 143, 155, 170, 181, 190, 196, 274], 'overall': [5, 319], 'survival': [6, 153, 320], 'associated': [7, 50, 259, 291], 'with': [8, 51, 57, 74, 80, 187, 260, 292, 323], 'metastatic': [9, 58, 75, 324], 'castration-resistant': [10], 'prostate': [11], 'cancer': [12], '(CRPC)': [13], 'treatments': [14], 'rely': [15], 'on': [16, 317], "patients'": [17], 'consistent': [18], 'adherence': [19, 32, 119, 273, 288, 316], 'to': [20, 33, 43, 101, 162, 302, 309], 'the': [21, 45, 66, 111, 115, 148, 164, 167, 171, 200, 210, 217, 311, 318], 'recommended': [22], 'dosage': [23], 'regimens.': [24], 'OBJECTIVES': [25], 'To': [26], 'evaluate': [27], 'treatment': [28, 79, 169, 186, 240], 'patterns': [29], 'patient': [31], 'abiraterone': [34, 81, 188, 204, 221, 261, 267], 'acetate': [35, 82, 189, 205, 222, 242, 268], 'or': [36, 83], 'enzalutamide': [37, 84, 284], 'therapy': [38, 269], 'in': [39, 55, 298], 'real-world': [40], 'practice,': [41], 'examine': [44], 'factors': [46], 'that': [47], 'may': [48, 289, 300], 'be': [49, 290], 'medication': [52, 131, 272, 287, 315], 'dose': [53, 136, 145, 174, 228, 234, 257, 278], 'reduction': [54, 137, 229, 258, 279], 'patients': [56, 73, 96, 183, 201, 211, 218, 322], 'CRPC.': [59, 325], 'METHODS': [60], 'Retrospective': [61], 'analyses': [62, 154], 'were': [63, 97, 108, 160, 245], 'conducted': [64], 'using': [65, 130, 140], 'Truven': [67], 'Health': [68], 'MarketScan': [69], 'research': [70, 306], 'databases': [71], 'among': [72], 'CRPC': [76], 'who': [77, 184, 202, 212, 219, 265, 282], 'initiated': [78, 185, 203, 213, 220, 266, 283], 'between': [85, 166], 'October': [86], '1,': [87], '2012,': [88], 'December': [90], '31,': [91], '2014': [92], '(index': [93], 'date).': [94], 'followed': [98], 'for': [99, 173, 233, 239, 256, 277], 'up': [100], '12': [102, 127, 197], 'months,': [103], 'their': [105], 'baseline': [106], 'characteristics': [107], 'assessed': [109], 'during': [110], '6': [112], 'months': [113, 128, 198], 'before': [114], 'index': [116], 'date.': [117], 'Medication': [118], 'was': [120, 138], 'measured': [121, 139], 'at': [122], '3,': [123], '6,': [124, 194], '9,': [125, 195], 'postindex': [129], 'possession': [132], 'ratios': [133, 238], '(MPRs),': [134], 'refill': [141], 'gaps': [142], 'relative': [144], 'intensity': [146], 'over': [147], 'entire': [149], 'observation': [150], 'period.': [151], 'Kaplan-Meier': [152, 225], 'Cox': [156], 'proportional': [157], 'hazards': [158], 'models': [159], 'used': [161], 'assess': [163, 310], 'association': [165], 'initial': [168], 'risk': [172, 255, 276], 'reduction.': [175, 235], 'RESULTS': [176], 'study': [178], 'included': [179], '2591': [180], '807': [182], 'enzalutamide,': [191], 'respectively.': [192], 'At': [193], 'postindex,': [199], 'had': [206, 223, 270], 'higher': [207, 271], 'MPRs': [208], 'than': [209, 248, 280], 'enzalutamide.': [214], 'In': [215], 'addition,': [216], 'lower': [224, 247, 254, 275], 'rates': [226], 'across': [230], '4': [231], 'measurements': [232], 'All': [236], 'hazard': [237], '(abiraterone': [241], 'vs': [243], 'enzalutamide)': [244], 'significantly': [246], '1': [249], '(range,': [250], '0.57-0.80),': [251], 'indicating': [252], 'a': [253], 'acetate.': [262], 'CONCLUSION': [263], 'Patients': [264], 'those': [281], 'therapy.': [285], 'Improved': [286], 'longer': [293], 'duration': [294], 'treatment,': [296], 'which': [297], 'turn': [299], 'lead': [301], 'better': [303], 'survival.': [304], 'Further': [305], 'is': [307], 'needed': [308], 'potential': [312], 'effect': [313]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2981596434', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 6}, {'year': 2021, 'cited_by_count': 7}, {'year': 2020, 'cited_by_count': 6}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 4}], 'updated_date': '2024-12-15T03:29:18.409688', 'created_date': '2019-11-01'}